Phenomen Pharma
Phenomen Pharma
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly | Chemically-Induced Disorders, Digestive System Diseases, Hepatomegaly, Hypertrophy, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, alcohol-induced disorders, alcohol-related disorders, alcoholic fatty liver disease, alcoholic liver disease, fatty liver disease, liver disorder, metabolic dysfunction-associated steatotic liver disease, substance-related disorder | Recruiting | Not applicable | 2025-07-23 | NCT07068191 |